This drug was developed to treat Ebola and now is also an experimental antiviral drug, says the World Health Organization (WHO). Although it failed against that vicious infection, it has shown effectiveness against MERS and SARS in laboratory and animal tests.
As you probably know, both MERS (Middle East Respiratory Syndrome) and SERS (Severe Acute Respiratory Syndrome) are related to the current Covid-19 virus, leading medical experts to assume that remdesivir might also work against COVID-19.
Remdesivir actually works by interfering with the virus’s ability to replicate, explains Dr. Desruisseaux, who is also an associate professor of internal medicine in the section of infectious diseases at Yale University School of Medicine in New Haven, Connecticut. The drug interfered with the virus’s capacity to replicate in cell cultures.
“We should have the results soon on whether or not it is effective in patients with Covid-19,” says Dr. Desruisseaux.
Now, this drug is in Phase 3 clinical trials and the results are expected in April or May. And, even if the results from those clinical trials are positive, however, remdesivir still needs to go through an approval process. Right now, patients can have access to remdesivir through a clinical trial or on a “compassionate use” basis, says the CDC.
Sometimes, a visit to the doctor could lead to you not getting what you needed… Read More
The most common cause of abdominal pain is digestive issues. Discomfort and irregularities in any… Read More
Constipation is a condition that appears when you're not having a healthy number of bowel… Read More
Failure to diagnose or delayed diagnosis are two examples of the most common allegations of… Read More
It's been almost two years since coronavirus has infiltrated our routines, changing our lives forever.… Read More
Your metabolic rate is very important, but what is it really? It's your body's ability… Read More